EVH - These Analysts Revise Their Forecasts On Evolent Health After Upbeat Results | Benzinga
Evolent Health, Inc. (NYSE: EVH) reported better-than-expected fourth-quarter results on Thursday.
Evolent Health posted quarterly earnings of 23 cents per share, beating market estimates of 15 cents per share. The company’s quarterly sales came in at $556.05 million versus market expectations of $542.39 million, according to data from Benzinga Pro.
Seth Blackley, Chief Executive Officer, and Co-Founder of Evolent stated, "We ended 2023 on a strong note, achieving all of our financial objectives for the year. Annual revenue increased over 45% while we continued to deliver strong earnings, driven by continued ...